Showing results (151-160 of 333) with videos related to
Sort By:
Pageof 34
Plos One|June 23, 2011
Determinants of non-vaccination against pandemic 2009 H1N1 influenza in pregnant women: a prospective cohort studyRomain Freund, Camille Le Ray, Caroline Charlier, et al.JAMA Internal Medicine|April 12, 2016
Long-term Immune Response to Hepatitis B Virus Vaccination Regimens in Adults With Human Immunodeficiency Virus 1: Secondary Analysis of a Randomized Clinical TrialOdile Launay, Arielle R Rosenberg, David Rey, et al.Vaccine|July 26, 2015
Diphtheria, tetanus, poliomyelitis, yellow fever and hepatitis B seroprevalence among HIV1-infected migrants. Results from the ANRS VIHVO vaccine sub-studyJimmy Mullaert, Sophie Abgrall, Nathalie Lele, et al.Infectious Diseases Now|December 17, 2021
Vaccine effectiveness against COVID-19 hospitalization in adults in France: A test negative case control studyLiem Binh Luong Ngyen, Rebecca Bauer, Zineb Lesieur, et al.Antiviral Therapy|February 17, 2007
Lamivudine and indinavir/ritonavir maintenance therapy in highly pretreated HIV-infected patients (Vista ANRS 109)Odile Launay, Xavier Duval, Cécile Dalban, et al.Journal of Infection and Public Health|October 18, 2011
Adherence to preventive measures after splenectomy in the hospital setting and in the communityHélène Coignard-Biehler, Fanny Lanternier, Arnaud Hot, et al.Blood|August 20, 2010
Glycosidic Tn-based vaccines targeting dermal dendritic cells favor germinal center B-cell development and potent antibody response in the absence of adjuvantTeresa Freire, Xiaoming Zhang, Edith Dériaud, et al.Autoimmunity Reviews|April 22, 2014
Autoimmune diseases in HIV-infected patients: 52 cases and literature reviewLaura Iordache, Odile Launay, Olivier Bouchaud, et al.Vaccine|August 9, 2017
Pneumococcal vaccination in patients with systemic lupus erythematosus: A multicenter placebo-controlled randomized double-blind studySophie Grabar, Matthieu Groh, Mathilde Bahuaud, et al.AIDS (London, England)|November 15, 2005
Absence of association between MDR1 genetic polymorphisms, indinavir pharmacokinetics and response to highly active antiretroviral therapyCéline Verstuyft, Fabienne Marcellin, Laurence Morand-Joubert, et al.Pageof 34